Patent application number | Description | Published |
20120121698 | PHARMACEUTICAL COMPOSITIONS COMPRISING EPA AND A CARDIOVASCULAR AGENT AND METHODS OF USING THE SAME - The present invention relates to, inter alia, pharmaceutical compositions comprising EPA and one or more cardiovascular agents, and to therapeutic methods for treating various diseases and disorders using the same. | 05-17-2012 |
20130252989 | STABLE PHARMACEUTICAL COMPOSITION AND METHODS OF USING SAME - The present invention relates to, inter alia, pharmaceutical compositions comprising a polyunsaturated fatty acid and to methods of using the same to treat or prevent cardiovascular-related diseases. | 09-26-2013 |
20130252990 | STABLE PHARMACEUTICAL COMPOSITION AND METHODS OF USING SAME - The present invention relates to, inter alia, pharmaceutical compositions comprising a polyunsaturated fatty acid and to methods of using the same to treat or prevent cardiovascular-related diseases. | 09-26-2013 |
20130253030 | METHODS OF TREATING MIXED DYSLIPIDEMIA - The present disclosure relates to, inter alia, methods of treating mixed dyslipidemia with ethyl eicosapentaenoate. | 09-26-2013 |
20130253031 | METHODS OF TREATING MIXED DYSLIPIDEMIA - The present disclosure relates to, inter alia, methods of treating mixed dyslipidemia with ethyl eicosapentaenoate. | 09-26-2013 |
20130274338 | PHARMACEUTICAL COMPOSITIONS COMPRISING DGLA, 15-OHEPA, AND/OR 15-HETRE AND METHODS OF REDUCING SEBUM PRODUCTION USING SAME - The present disclosure provides compositions comprising fatty acids, or derivatives thereof (e.g., C1-C4 esters) including, for example, DGLA, 15-OHEPA and/or 15-HETrE, used singly or in combination with anti-bacterial agents for the inhibition of sebum production. | 10-17-2013 |
20130281534 | COMPOSITIONS AND METHODS FOR LOWERING TRIGLYCERIDES WITHOUT RAISING LDL-C LEVELS IN A SUBJECT ON CONCOMITANT STATIN THERAPY - In various embodiments, the present invention provides compositions and methods for treating and/or preventing cardiovascular-related diseases in subject in need thereof. | 10-24-2013 |
20130331447 | METHODS OF TREATING HYPERTRIGLYCERIDEMIA - In various embodiments, the present invention provides methods of treating and/or preventing cardiovascular-related disease and, in particular, a method of blood lipid therapy comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof. | 12-12-2013 |
20140017306 | STABLE PHARMACEUTICAL COMPOSITION AND METHODS OF USING SAME - The present invention relates to, inter alia, pharmaceutical compositions comprising a polyunsaturated fatty acid and to methods of using the same to treat or prevent cardiovascular-related diseases. | 01-16-2014 |
20140066507 | COSMETIC COMPOSITIONS COMPRISING EPA AND SALICYLIC ACID AND METHODS OF MAKING AND USING SAME - The present disclosure is directed generally to cosmetic compositions comprising EPA free acid and salicylic acid. In some embodiments, the cosmetic compositions have a cosmetically acceptable odor. | 03-06-2014 |
20140066509 | COSMETIC COMPOSITIONS COMPRISING EPA AND GLA AND METHODS OF MAKING AND USING SAME - The present disclosure is directed generally to cosmetic compositions comprising EPA free acid and GLA free acid. In some embodiments, the cosmetic compositions have a cosmetically acceptable odor. | 03-06-2014 |
20140080909 | STABLE PHARMACEUTICAL COMPOSITION AND METHODS OF USING SAME - The present invention relates to, inter alia, pharmaceutical compositions comprising a polyunsaturated fatty acid and to methods of using the same to treat or prevent cardiovascular-related diseases. | 03-20-2014 |
20140088194 | STABLE PHARMACEUTICAL COMPOSITION AND METHODS OF USING SAME - The present invention relates to, inter alia, pharmaceutical compositions comprising a polyunsaturated fatty acid and to methods of using the same to treat or prevent cardiovascular-related diseases. | 03-27-2014 |
20140154310 | PHARMACEUTICAL COMPOSITIONS COMPRISING FATTY ACIDS - The present disclosure relates to, inter alia, methods of treating mixed dyslipidemia with ethyl eicosapentaenoate. | 06-05-2014 |
20140155455 | PHARMACEUTICAL COMPOSITIONS COMPRISING EPA AND A CARDIOVASCULARAGENT AND METHODS OF USING THE SAME - The present disclosure relates to, inter alia, methods of treating mixed dyslipidemia with ethyl eicosapentaenoate. | 06-05-2014 |
20140155481 | COMPOSITIONS AND METHODS FOR LOWERING TRIGLYCERIDES IN A SUBJECT ON CONCOMITANT STATIN THERAPY - In various embodiments, the present invention provides compositions and methods for treating and/or preventing cardiovascular-related diseases in subject in need thereof. | 06-05-2014 |
20140171358 | ANTIMICROBIAL COMPOSITIONS COMPRISING DGLA AND NEOMYCIN SULFATE AND METHODS OF USE THEREOF - The present disclosure provides compositions comprising fatty acids, or derivatives thereof (e.g., C1-C4 esters) including, for example, DGLA, 15-OHEPA and/or 15-HETrE, used alone or in combination with one or more antibiotic agents for the treatment of disease and/or disorders such as a skin infection or wound healing. | 06-19-2014 |
20140186438 | COMPOSITIONS COMPRISING EPA AND OBETICHOLIC ACID AND METHODS OF USE THEREOF - In various embodiments, the present invention provides compositions comprising eicosapentaenoic acid or a derivative thereof and obeticholic acid or a derivative thereof. In other embodiments, the present invention provides methods of treating and/or preventing NASH and/or PBC comprising co-administering to a subject in need thereof eicosapentaenoic acid or a derivative thereof and obeticholic acid or a derivative thereof. | 07-03-2014 |
20140187633 | METHODS OF TREATING OR PREVENTING NONALCOHOLIC STEATOHEPATITIS AND/OR PRIMARY BILIARY CIRRHOSIS - In various embodiments, the present invention provides methods of treating and/or preventing NASH and/or PBC comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof. | 07-03-2014 |
20140213648 | METHODS OF INCREASING EPA BLOOD LEVELS - In various embodiments, the present invention provides methods of treating and/or preventing cardiovascular-related disease and, in particular, a method of blood lipid therapy comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof. | 07-31-2014 |
20140221486 | METHODS OF REDUCING APOLIPOPROTEIN C-III - In various embodiments, the present invention provides methods of treating and/or preventing cardiovascular-related disease and, in particular, a method of blood lipid therapy comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof. | 08-07-2014 |
20140235716 | STABLE PHARMACEUTICAL COMPOSITION AND METHODS OF USING SAME - The present invention relates to, inter alia, pharmaceutical compositions comprising a polyunsaturated fatty acid and to methods of using the same to treat or prevent cardiovascular-related diseases. | 08-21-2014 |
20150080329 | PHARMACEUTICAL COMPOSITIONS COMPRISING DHA, EPA, AND/OR GLA AND AN ANTIBIOTIC AGENT AND METHODS OF USE THEREOF - The present disclosure provides compositions comprising fatty acids, or derivatives thereof (e.g., C1-C4 esters) including, for example, DHA, EPA and/or GLA, used in combination with one or more antibiotic agents for the treatment of disease and/or disorders such as a skin or ocular infection. | 03-19-2015 |
20150093344 | PHARMACEUTICAL COMPOSITIONS COMPRISING DGLA AND/OR 15-HETRE AND METHODS OF USE THEREOF - The present disclosure provides compositions comprising fatty acids, or derivatives thereof (e.g., C1-C4 esters) including, for example, DGLA, and/or 15-HETrE, used singly or in combination for the prevention and/or treatment of effects associated with UV radiation such as erythema. | 04-02-2015 |
20150094370 | PHARMACEUTICAL COMPOSITIONS COMPRISING DGLA, 15-OHEPA, AND/OR 15-HETRE AND METHODS OF REDUCING SEBUM PRODUCTION USING SAME - The present disclosure provides compositions comprising fatty acids, or derivatives thereof (e.g., C1-C4 esters) including, for example, DGLA, 15-OHEPA and/or 15-HETrE, used singly or in combination with anti-bacterial agents for the inhibition of sebum production. | 04-02-2015 |
20150119593 | METHODS OF MAKING 15-HYDROXY FATTY ACID DERIVATIVES - The present disclosure provides methods of making 15-hydroxy fatty acid derivatives, such as 15-(S)-hydroxyeicosatrienoic acid (HETrE or 15-(S)-HETrE) or 15(S)-hydroxyeicosapentaenoic acid (HEPE or 15(S)-HEPE) from the corresponding fatty acid (e.g., dihomo-γ-linolenic acid (DGLA) or eicosapentaenoic acid (EPA), respectively). In some embodiments, the method comprises contacting the fatty acid with an oxidizing agent (e.g., a lipoxygenase and oxygen) in the presence of a reducing agent (e.g., cysteine) to form the 15-hydroxy fatty acid derivatives in a single reaction vessel. | 04-30-2015 |
20150152034 | Pharmaceutically Acceptable Salts of Fatty Acids - The present disclosure provides pharmaceutically acceptable stable salt forms of 15-lipoxygenase products, such as 15-HETrE lysine salt, compositions comprising same and methods of making and using same. | 06-04-2015 |
20150190361 | COMPOSITIONS AND METHODS FOR LOWERING TRIGLYCERIDES IN A SUBJECT ON CONCOMITANT STATIN THERAPY - In various embodiments, the present invention provides compositions and methods for treating and/or preventing cardiovascular-related diseases in subject in need thereof. | 07-09-2015 |
20150196521 | PHARMACEUTICAL COMPOSITIONS COMPRISING 15-HEPE AND METHODS OF TREATING ASTHMA AND LUNG DISORDERS USING SAME - The disclosure provides compositions comprising 15-HEPE or derivatives thereof used singly or in combination with other active agents for the treatment and/or prevention of lung diseases and disorders such as asthma. | 07-16-2015 |
20150216831 | Methods of Reducing Apolipoprotein C-III - In various embodiments, the present invention provides methods of treating and/or preventing cardiovascular-related disease and, in particular, a method of blood lipid therapy comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof. | 08-06-2015 |
20150238455 | STABLE PHARMACEUTICAL COMPOSITION AND METHODS OF USING SAME - The present invention relates to, inter alia, pharmaceutical compositions comprising a polyunsaturated fatty acid and to methods of using the same to treat or prevent cardiovascular-related diseases. | 08-27-2015 |
20150258051 | METHODS OF INCREASING EPA BLOOD LEVELS - In various embodiments, the present invention provides methods of treating and/or preventing cardiovascular-related disease and, in particular, a method of blood lipid therapy comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof. | 09-17-2015 |
20150265566 | Compositions and Methods for Lowering Triglycerides without Raising LDL-C Levels in a Subject on Concomitant Statin Therapy - In various embodiments, the present invention provides compositions and methods for treating and/or preventing cardiovascular-related diseases in subject in need thereof. | 09-24-2015 |
20150272917 | PHARMACEUTICAL COMPOSITIONS COMPRISING OMEGA-3 FATTY ACIDS - The present disclosure relates to, inter alia, pharmaceutical compositions comprising omega-3 fatty acids. | 10-01-2015 |
20150290225 | COMPOSITIONS AND METHODS OF USING SAME - The present disclosure provides compositions and methods for the treatment of disease and/or disorders of this skin. | 10-15-2015 |
Patent application number | Description | Published |
20110034555 | COMPOSITIONS AND METHODS FOR LOWERING TRIGLYCERIDES WITHOUT RAISING LDL-C LEVELS IN A SUBJECT ON CONCOMITANT STATIN THERAPY - In various embodiments, the present invention provides compositions and methods for treating and/or preventing cardiovascular-related diseases in subject in need thereof. | 02-10-2011 |
20110288171 | METHODS OF TREATING HYPERTRIGLYCERIDEMIA - In various embodiments, the present invention provides methods of treating and/or preventing cardiovascular-related disease and, in particular, a method of blood lipid therapy comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof. | 11-24-2011 |
20120035262 | COMPOSITIONS AND METHODS FOR LOWERING TRIGLYCERIDES - In various embodiments, the present invention provides compositions and methods for treating and/or preventing cardiovascular-related diseases in subject in need thereof. | 02-09-2012 |
20120039997 | METHODS OF TREATING HYPERTRIGLYCERIDEMIA - In various embodiments, the present invention provides methods of treating and/or preventing cardiovascular-related disease and, in particular, a method of blood lipid therapy comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof. | 02-16-2012 |
20120093924 | METHODS OF TREATING HYPERTRIGLYCERIDEMIA - In various embodiments, the present invention provides methods of treating and/or preventing cardiovascular-related disease and, in particular, a method of blood lipid therapy comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof. | 04-19-2012 |
20120100208 | STABLE PHARMACEUTICAL COMPOSITION AND METHODS OF USING SAME - The present invention relates to, inter alia, pharmaceutical compositions comprising a polyunsaturated fatty acid and to methods of using the same to treat or prevent cardiovascular-related diseases. | 04-26-2012 |
20120108659 | METHODS OF TREATING HYPERTRIGLYCERIDEMIA - In various embodiments, the present invention provides methods of treating and/or preventing cardiovascular-related disease and, in particular, a method of blood lipid therapy comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof. | 05-03-2012 |
20120108660 | METHODS OF TREATING HYPERTRIGLYCERIDEMIA - In various embodiments, the present invention provides methods of treating and/or preventing cardiovascular-related disease and, in particular, a method of blood lipid therapy comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof. | 05-03-2012 |
20120108663 | METHODS OF TREATING HYPERTRIGLYCERIDEMIA - In various embodiments, the present invention provides methods of treating and/or preventing cardiovascular-related disease and, in particular, a method of blood lipid therapy comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof. | 05-03-2012 |
20120156285 | METHODS OF TREATING HYPERTRIGLYCERIDEMIA - In various embodiments, the present invention provides methods of treating and/or preventing cardiovascular-related disease and, in particular, a method of blood lipid therapy comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof | 06-21-2012 |
20120157530 | METHODS OF TREATING HYPERTRIGLYCERIDEMIA - In various embodiments, the present invention provides methods of treating and/or preventing cardiovascular-related disease and, in particular, a method of blood lipid therapy comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof. | 06-21-2012 |
20120157531 | COMPOSITIONS AND METHODS FOR LOWERING TRIGLYCERIDES - In various embodiments, the present invention provides compositions and methods for treating and/or preventing cardiovascular-related diseases in subject in need thereof. | 06-21-2012 |
20120172432 | PHARMACEUTICAL COMPOSITIONS COMPRISING EPA AND A CARDIOVASCULAR AGENT AND METHODS OF USING THE SAME - The present invention relates to, inter alia, pharmaceutical compositions comprising EPA and one or more cardiovascular agents, and to therapeutic methods for treating various diseases and disorders using the same. | 07-05-2012 |
20120225120 | STABLE PHARMACEUTICAL COMPOSITION AND METHODS OF USING SAME - The present invention relates to, inter alia, pharmaceutical compositions comprising a polyunsaturated fatty acid and to methods of using the same to treat or prevent cardiovascular-related diseases. | 09-06-2012 |
20120232145 | COMPOSITIONS AND METHODS FOR LOWERING TRIGLYCERIDES IN A SUBJECT ON CONCOMITANT STATIN THERAPY - In various embodiments, the present invention provides compositions and methods for treating and/or preventing cardiovascular-related diseases in subject in need thereof. | 09-13-2012 |
20120232147 | PHARMACEUTICAL COMPOSITIONS COMPRISING DGLA, 15-OHEPA, AND/OR 15-HETRE AND METHODS OF USE THEREOF - The present disclosure provides compositions comprising fatty acids, or derivatives thereof (e.g., C1-C4 esters) including, for example, DGLA, 15-OHEPA and/or 15-HETrE, used singly or in combination with anti-bacterial agents for the treatment of disease and/or disorders such as acne or atopic dermatitis. | 09-13-2012 |
20120237594 | METHODS OF TREATING HYPERTRIGLYCERIDEMIA - In various embodiments, the present invention provides methods of treating and/or preventing cardiovascular-related disease and, in particular, a method of blood lipid therapy comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof | 09-20-2012 |
20120264705 | ANTIMICROBIAL COMPOSITIONS COMPRISING 15-HETRE AND METHODS OF USE THEREOF - The present disclosure provides compositions comprising fatty acids, or derivatives thereof (e.g., C1-C4 esters) including, for example, DGLA, 15-OHEPA and/or 15-HETrE, used alone or in combination with one or more antibiotic agents for the treatment of disease and/or disorders such as a skin infection or wound healing. | 10-18-2012 |
20120302589 | PHARMACEUTICAL COMPOSITIONS COMPRISING EPA AND A CARDIOVASCULAR AGENT AND METHODS OF USING THE SAME - The present invention relates to, inter alia, pharmaceutical compositions comprising EPA and one or more cardiovascular agents, and to therapeutic methods for treating various diseases and disorders using the same. | 11-29-2012 |
20130004566 | METHODS OF TREATING HYPERTRIGLYCERIDEMIA - In various embodiments, the present invention provides methods of treating and/or preventing cardiovascular-related disease and, in particular, a method of blood lipid therapy comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof | 01-03-2013 |
20130004567 | METHODS OF TREATING HYPERTRIGLYCERIDEMIA - In various embodiments, the present invention provides methods of treating and/or preventing cardiovascular-related disease and, in particular, a method of blood lipid therapy comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof. | 01-03-2013 |
20130004568 | METHODS OF TREATING HYPERTRIGLYCERIDEMIA - In various embodiments, the present invention provides methods of treating and/or preventing cardiovascular-related disease and, in particular, a method of blood lipid therapy comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof. | 01-03-2013 |
20130004572 | STABLE PHARMACEUTICAL COMPOSITION AND METHODS OF USING SAME - The present invention relates to, inter alia, pharmaceutical compositions comprising a polyunsaturated fatty acid and to methods of using the same to treat or prevent cardiovascular-related diseases. | 01-03-2013 |
20130005757 | PHARMACEUTICAL COMPOSITIONS COMPRISING EPA AND A CARDIOVASCULAR AGENT AND METHODS OF USING THE SAME - The present invention relates to, inter alia, pharmaceutical compositions comprising EPA and one or more cardiovascular agents, and to therapeutic methods for treating various diseases and disorders using the same. | 01-03-2013 |
20130005809 | METHODS OF TREATING HYPERTRIGLYCERIDEMIA - In various embodiments, the present invention provides methods of treating and/or preventing cardiovascular-related disease and, in particular, a method of blood lipid therapy comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof. | 01-03-2013 |
20130011471 | STABLE PHARMACEUTICAL COMPOSITION AND METHODS OF USING SAME - The present invention relates to, inter alia, pharmaceutical compositions comprising a polyunsaturated fatty acid and to methods of using the same to treat or prevent cardiovascular-related diseases. | 01-10-2013 |
20130011472 | STABLE PHARMACEUTICAL COMPOSITION AND METHODS OF USING SAME - The present invention relates to, inter alia, pharmaceutical compositions comprising a polyunsaturated fatty acid and to methods of using the same to treat or prevent cardiovascular-related diseases. | 01-10-2013 |
20130012580 | COMPOSITIONS AND METHODS FOR LOWERING TRIGLYCERIDES WITHOUT RAISING LDL-C LEVELS IN A SUBJECT ON CONCOMITANT STATIN THERAPY - In various embodiments, the present invention provides compositions and methods for treating and/or preventing cardiovascular-related diseases in subject in need thereof. | 01-10-2013 |
20130017256 | METHODS OF TREATING HYPERTRIGLYCERIDEMIA - In various embodiments, the present invention provides methods of treating and/or preventing cardiovascular-related disease and, in particular, a method of blood lipid therapy comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof. | 01-17-2013 |
20130079409 | STABLE PHARMACEUTICAL COMPOSITION AND METHODS OF USING SAME - The present invention relates to, inter alia, pharmaceutical compositions comprising a polyunsaturated fatty acid and to methods of using the same to treat or prevent cardiovascular-related diseases. | 03-28-2013 |
20130090383 | STABLE PHARMACEUTICAL COMPOSITION AND METHODS OF USING SAME - The present invention relates to, inter alia, pharmaceutical compositions comprising a polyunsaturated fatty acid and to methods of using the same to treat or prevent cardiovascular-related diseases. | 04-11-2013 |
20130095178 | PHARMACEUTICAL COMPOSITION COMPRISING EICOSAPENTAENOIC ACID AND NICOTINIC ACID AND METHODS OF USING SAME - The present invention relates to, inter alia, pharmaceutical compositions comprising eicosapentaenoic acid and/or derivatives thereof and nicotinic acid, to methods of manufacturing such compositions, and to therapeutic methods for treating carious diseases and disorders. | 04-18-2013 |
20130096197 | METHODS OF TREATING HYPERTRIGLYCERIDEMIA - In various embodiments, the present invention provides methods of treating and/or preventing cardiovascular-related disease and, in particular, a method of blood lipid therapy comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof. | 04-18-2013 |
20130101533 | PHARMACEUTICAL COMPOSITIONS COMPRISING DGLA AND/OR 15-HETRE AND METHODS OF USE THEREOF - The present disclosure provides compositions comprising fatty acids, or derivatives thereof (e.g., C1-C4 esters) including, for example, DGLA, and/or 15-HETrE, used singly or in combination for the prevention and/or treatment of effects associated with UV radiation such as erythema. | 04-25-2013 |
20130102575 | PHARMACEUTICAL COMPOSITIONS COMPRISING DGLA, 15-OHEPA, AND/OR 15-HETRE AND METHODS OF USE THEREOF - The present disclosure provides compositions comprising fatty acids, or derivatives thereof (e.g., C1-C4 esters) including, for example, DGLA, 15-OHEPA and/or 15-HETrE, used singly or in combination with anti-bacterial agents for the treatment of disease and/or disorders such as acne or atopic dermatitis. | 04-25-2013 |
20130102674 | METHODS OF TREATING HYPERTRIGLYCERIDEMIA - In various embodiments, the present invention provides methods of treating and/or preventing cardiovascular-related disease and, in particular, a method of blood lipid therapy comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof. | 04-25-2013 |
20130131170 | METHODS OF TREATING HYPERTRIGLYCERIDEMIA - In various embodiments, the present invention provides methods of treating and/or preventing cardiovascular-related disease and, in particular, a method of blood lipid therapy comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof. | 05-23-2013 |
20130156852 | STABLE PHARMACEUTICAL COMPOSITION AND METHODS OF USING SAME - The present invention relates to, inter alia, pharmaceutical compositions comprising a polyunsaturated fatty acid and to methods of using the same to treat or prevent cardiovascular-related diseases. | 06-20-2013 |
20130158120 | STABLE PHARMACEUTICAL COMPOSITION AND METHODS OF USING SAME - The present invention relates to, inter alia, pharmaceutical compositions comprising a polyunsaturated fatty acid and to methods of using the same to treat or prevent cardiovascular-related diseases. | 06-20-2013 |
20130164375 | METHODS OF TREATING HYPERTRIGLYCERIDEMIA - In various embodiments, the present invention provides methods of treating and/or preventing cardiovascular-related disease and, in particular, a method of blood lipid therapy comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof | 06-27-2013 |
20130165513 | STABLE PHARMACEUTICAL COMPOSITION AND METHODS OF USING SAME - The present invention relates to, inter alia, pharmaceutical compositions comprising a polyunsaturated fatty acid and to methods of using the same to treat or prevent cardiovascular-related diseases. | 06-27-2013 |
20130171249 | METHODS OF TREATING HYPERTRIGLYCERIDEMIA - In various embodiments, the present invention provides methods of treating and/or preventing cardiovascular-related disease and, in particular, a method of blood lipid therapy comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof. | 07-04-2013 |
20130171250 | METHODS OF TREATING HYPERTRIGLYCERIDEMIA - In various embodiments, the present invention provides methods of treating and/or preventing cardiovascular-related disease and, in particular, a method of blood lipid therapy comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof. | 07-04-2013 |
20130171251 | STABLE PHARMACEUTICAL COMPOSITION AND METHODS OF USING SAME - The present invention relates to, inter alia, pharmaceutical compositions comprising a polyunsaturated fatty acid and to methods of using the same to treat or prevent cardiovascular-related diseases. | 07-04-2013 |
20130172413 | STABLE PHARMACEUTICAL COMPOSITION AND METHODS OF USING SAME - The present invention relates to, inter alia, pharmaceutical compositions comprising a polyunsaturated fatty acid and to methods of using the same to treat or prevent cardiovascular-related diseases. | 07-04-2013 |
20130189355 | COMPOSITIONS AND METHODS FOR LOWERING LEVELS OF HIGH-SENSITIVITY (HS-CRP) IN A SUBJECT - The present disclosure provides methods for treating and/or preventing cardiovascular-related disease and, in particular, a method of blood lipid therapy comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof. In some embodiments, the method comprises lowering high sensitivity CRP (hs-CRP) levels in a subject including, for example, a subject with a HbA | 07-25-2013 |
20130195972 | PHARMACEUTICAL COMPOSITIONS COMPRISING EPA AND A CARDIOVASCULAR AGENT AND METHODS OF USING THE SAME - The present invention relates to, inter alia, pharmaceutical compositions comprising EPA and one or more cardiovascular agents, and to therapeutic methods for treating various diseases and disorders using the same. | 08-01-2013 |
20130267598 | PHARMACEUTICAL COMPOSITIONS COMPRISING DGLA, 15-OHEPA, AND/OR 15-HETRE AND METHODS OF REDUCING SEBUM PRODUCTION USING SAME - The present disclosure provides compositions comprising fatty acids, or derivatives thereof (e.g., C1-C4 esters) including, for example, DGLA, 15-OHEPA and/or 15-HETrE, used singly or in combination with anti-bacterial agents for the inhibition of sebum production. | 10-10-2013 |
20130331448 | COMPOSITIONS COMPRISING 20-CARBON FATTY ACIDS AND METHODS OF MAKING AND USING SAME - The present disclosure provides a process for producing 20-carbon fatty acids from a plant seed oil, the process comprising: a) providing a plant seed oil comprising fatty acids, wherein the fatty acids include 18-carbon fatty acids; and b) elongating the fatty acids by two carbon atoms to produce a composition comprising 20-carbon fatty acids. | 12-12-2013 |
Patent application number | Description | Published |
20090021321 | HYBRID LINEAR AND POLAR MODULATION APPARATUS - The invention is directed at a hybrid modulation apparatus which combines a polar modulation circuit and a linear modulation circuit. The hybrid apparatus allows a communications device to function as a polar or a linear modulation circuit with less components as the output of the linear modulation circuit is an input of the polar modulation circuit. | 01-22-2009 |
20100027596 | CLOSED-LOOP DIGITAL POWER CONTROL FOR A WIRELESS TRANSMITTER - A closed loop power output calibration system for variable power output wireless devices. The wireless device includes a wireless transceiver having a transmit core coupled to a discrete power amplifier. Power detection circuitry formed in the wireless transceiver provides a detected power level of the power amplifier, and a reference power level, both of which are converted to digital signals using existing I and Q signal analog to digital converters in the receiver core. The digital signals are processed to cancel power distortion and temperature effects to provide a resulting power feedback signal. Corrective control signals are generated in response to the power feedback signal relative to a desired power output level. The gain in the transmit core is then adjusted in response to the corrective control signals such that the power amplifier outputs the target output power level. | 02-04-2010 |
20100027711 | DIGITAL LINEAR TRANSMITTER ARCHITECTURE - A digital linear transmitter for digital to analog conversion of a radio frequency signal. The transmitter includes a delta sigma (ΔΣ) digital to analog converter (DAC) and a weighted signal digital to analog converter in the transmit path of a wireless device to reduce reliance on relatively large analog components. The ΔΣ DAC converts the lowest significant bits of the oversampled signal while the weighted signal digital to analog converter converts the highest significant bits of the oversampled signal. The transmitter core includes components for providing an oversampled modulated digital signal which is then subjected to first order filtering of the oversampled signal prior to generating a corresponding analog signal. The apparatus and method reduces analog components and increases digital components in transmitter core architecture of wireless RF devices. | 02-04-2010 |
20100029228 | EDGE POWER RAMP USING LOGARITHMIC RESISTOR ATTENUATOR - A power ramping circuit for use in the transmit path of a radio frequency (RF) circuit. The power ramping circuit includes parallel connected transistors used as logarithmic resistor attenuators for adjusting current to a mixer circuit in the transmit path. The parallel connected transistors can be sized differently, and are sequentially turned off to gradually increase the current provided to the mixer circuit. A ramp control circuit controls the parallel connected transistors in response to either an analog signal or a digital signal. | 02-04-2010 |
20100060333 | DIGITAL CHARGE PUMP PLL ARCHITECTURE - A digital phase lock loop (PLL) circuit having a digital charge pump circuit for providing digital signals corresponding to a difference in phase between an internal clock corresponding to a voltage controlled oscillator, and a reference clock. These digital signals are processed by a digital processing circuit for providing digital control signals. Some of the digital control signals are converted into an analog control signal to provide fine control of the voltage controlled oscillator, while the remaining digital control signals provide coarse control of the voltage controlled oscillator. | 03-11-2010 |
20100154044 | MULTI-TRANSPORT MODE DEVICES HAVING IMPROVED DATA THROUGHPUT - A method for transmitting data between a client and a server is provided. The method comprising the following steps. The data is segmented into a plurality of data packets, which are scheduled to be transmitted via different ones of a plurality of access points. Each of the plurality of access points is configured to communicate with the client using a different protocol and communicate with the server using a different network path. Each of the plurality of data packets is transmitted between the client and the server via the scheduled access point. A client device and proxy server configured to implement the method are also provided, as is a computer readable medium having stored thereon instructions for implementing the method. | 06-17-2010 |
20120022968 | USING A FIRST NETWORK TO CONTROL ACCESS TO A SECOND NETWORK - A wireless communication device is configured to be able to communicate via both a first access point and a second access point for using the first access point to obtain validation credentials in order to permit use of the second access point to access a network. The wireless communication device comprises a processor; and a non-transitory computer readable medium having stored thereon computer executable instructions. The instructions are operable to: initiate communication with the second access point in order to access a network; obtain an access point identifier from the second access point, the access point identifier for identifying the second access point; transmit the access point identifier to a validation server via the first access point; receive validation credentials from the validation server via the first access point; and use the validation credentials to validate the wireless communication device with the second access point to obtain access to the network. | 01-26-2012 |
20120116886 | USING A FIRST NETWORK TO CONTROL ACCESS TO A SECOND NETWORK - A wireless communication device is configured to be able to communicate via both a first access point and a second access point for using the first access point to obtain validation credentials in order to permit use of the second access point to access a network. The wireless communication device comprises a processor; and a non-transitory computer readable medium having stored thereon computer executable instructions. The instructions are operable to: initiate communication with the second access point in order to access a network; obtain an access point identifier from the second access point, the access point identifier for identifying the second access point; transmit the access point identifier to a validation server via the first access point; receive validation credentials from the validation server via the first access point; the validation credentials including at identifier of a third party, the third party sponsoring access to the second access point; use the validation credentials to validate the wireless communication device with the second access point to obtain access to the network; and present advertising information on the wireless communication device, the advertising information pertaining to the third party. | 05-10-2012 |
20120120962 | COMMUNICATION BETWEEN CLIENT AND SERVER USING MULTIPLE NETWORKS - A system is provided to facilitate communication with a client via both a first network and a second network. The system comprises a plurality of bandwidth aggregation servers, each bandwidth aggregation server configured to aggregate data packets received from the client via both the first and second networks for transmission to a destination server; and transmit data packets to the client via both the first and second networks in accordance with a scheduling algorithm, the data packets being received from a source server. | 05-17-2012 |
20120243578 | ELECTRONIC DEVICE WITH VCO PULLING COMPENSATION CIRCUIT FOR AN INPUT BASEBAND SIGNAL AND ASSOCIATED METHODS - An electronic device includes a transmitter with a baseband input for a baseband signal, a mixer downstream from the baseband input, and a phase-locked loop (PLL) having a voltage controlled oscillator (VCO) and a phase detector coupled thereto, the VCO coupled to the mixer. A power amplifier is downstream from the mixer, and generates at least one aggressing signal that would otherwise generate an output pull of the VCO, causing transmit distortion on a transmit signal. A receiver is coupled to the power amplifier and has a sense input configured to receive the transmit signal. A VCO pulling compensation circuit is coupled to the baseband input and is configured to compensate the at least one baseband signal for the transmit distortion based upon the sensed transmit signal. | 09-27-2012 |
20130082853 | DIGITAL TO ANALOG CONVERTER - A digital-to-analog converter is disclosed. The converter includes a gradient correction module that generates a correction term based on a model of gradient error. The correction term is then applied to the signal path in the digital domain or applied to the output of the digital-to-analog converter in the analog domain. The model used to generate the correction term is based on a vertical gradient error in the array of current source elements, which may be modelled and calibrated using a second-order polynomial. Further, a digital-to-analog converter having a Nyquist DAC and an oversampled DAC is disclosed. When the oversampled DAC is enabled, the resolution of the Nyquist DAC may be increased while slowing the conversion rate. | 04-04-2013 |
20130299579 | METHOD AND APPARATUS FOR GENERATING DEDICATED DATA CHANNELS IN BACKSCATTER RFID SYSTEMS - An antenna apparatus for backscattering an incoming radio frequency (RF) signal includes an antenna for backscattering the incoming RF signal in accordance with a reflection coefficient characteristic of the antenna. A variable impedance circuit includes an output electrically connected to the antenna. A low pass delta sigma modulator is coupled to the variable impedance circuit and digitally controls the output of the variable impedance circuit, such that the reflection coefficient of the antenna is adjusted based on the output of the variable impedance circuit. | 11-14-2013 |
20130300619 | METHOD AND APPARATUS FOR GENERATING DEDICATED DATA CHANNELS IN BACKSCATTER RFID SYSTEMS USING BAND-PASS MODULATION - An antenna apparatus for backscattering an incoming radio frequency (RF) signal includes an antenna for backscattering the incoming RF signal in accordance with a reflection coefficient characteristic of the antenna. A variable impedance circuit includes an output electrically connected to the antenna. A band-pass delta sigma modulator is coupled to the variable impedance circuit and digitally controls the output of the variable impedance circuit, such that the reflection coefficient of the antenna is adjusted based on the digitally controlled output of the variable impedance circuit. In an RFID network, the apparatus and method reduces the effect of DC offset in the reader device and the effects of the reader device's phase noise, while allowing for complex modulations. | 11-14-2013 |
20130324032 | Method and Apparatus for Generating Dedicated Data Channels in Inductive Coupled RFID Systems - An inductive coupling apparatus for modifying an incoming radio frequency (RF) signal includes an inductive element for modifying the incoming RF signal in accordance with a coupled impedance characteristic of the inductive element. A variable impedance circuit includes an output electrically coupled to the inductive element. A low pass delta sigma modulator is coupled to the variable impedance circuit and digitally controls the output of the variable impedance circuit, the coupled impedance of the inductive element being adjusted based on the output of the variable impedance circuit. | 12-05-2013 |
20130324033 | Method and Apparatus for Generating Dedicated Data Channels in Inductive Coupled RFID Systems Using Band-Pass Modulation - An inductive coupling apparatus for modifying an incoming radio frequency (RF) signal includes an inductive element. A variable impedance circuit includes an output electrically coupled to the inductive element. A band-pass delta sigma modulator is coupled to the variable impedance circuit and digitally controls the output of the variable impedance circuit. The incoming RF signal is modified as the coupled impedance of the inductive element is adjusted in accordance with the output of the variable impedance circuit. | 12-05-2013 |
20140016719 | TRANSMISSION APPARATUS FOR A WIRELESS DEVICE - A transmission apparatus for a wireless device, comprising: an antenna for receiving an original signal and for backscattering a modulated signal containing information from the wireless device; a variable impedance coupled to the antenna, the variable impedance having an impedance value; and, a decoder coupled to the variable impedance for modulating the impedance value, and thereby a backscattering coefficient for the antenna, in accordance with the information to generate the modulated signal. | 01-16-2014 |
20140029480 | TRANSCEIVER FILTER AND TUNING - A radio transceiver including a transmitter and a receiver. A filter coupled to an output of the transmitter, the filter has one or more inductors and one or more capacitors, where the filter is tuned by varying one or more capacitance values of the one or more capacitors in the filter to tune the filter. The one or more capacitors are Barium Strontium Titanate (BST) ceramic integrated capacitors that are each tuned by application of a bias voltage thereto. A filter tuner circuit is configured to apply the bias voltage to the one or more capacitors, where the bias voltage is initially established as a stored initial value, and where the bias voltage is refined by a proportional-integral-derivative (PID) controller configured to optimize a power within the transceiver. This abstract is not to be considered limiting since various implementations may incorporate more, fewer or different elements. | 01-30-2014 |
20140029481 | TRANSCEIVER FILTER AND TUNING - A radio transceiver including a transmitter and a receiver. A filter coupled to an output of the transmitter, the filter has one or more inductors and one or more capacitors, where the filter is tuned by varying one or more capacitance values of the one or more capacitors in the filter to tune the filter. The one or more capacitors are Barium Strontium Titanate (BST) ceramic integrated capacitors that are each tuned by application of a bias voltage thereto. A filter tuner circuit is configured to apply the bias voltage to the one or more capacitors, where the bias voltage is initially established as a stored initial value, and where the bias voltage is refined by a proportional-integral-derivative (PID) controller configured to optimize a power within the transceiver. This abstract is not to be considered limiting since various implementations may incorporate more, fewer or different elements. | 01-30-2014 |
20140038532 | MOBILE WIRELESS COMMUNICATIONS DEVICE WITH LNA FRONT END CIRCUIT AND RELATED METHODS - A mobile wireless communications device may include an antenna, LTE RF differential inputs, and a front end circuit. The front end circuit may include band pass filters coupled to the antenna, LNAs coupled respectively to the band pass filters, and RF switching circuits. Each RF switching circuit may be respectively coupled between each LNA and a pair of LTE RF differential inputs and configured to switch to one or both of the pair of LTE RF differential inputs. | 02-06-2014 |
20140273889 | ESTIMATION AND REDUCTION OF SECOND ORDER DISTORTION IN REAL TIME - A radio receiver method of reducing second order distortion components involves at a first mixer, mixing an input signal with an oscillator signal to generate an I component of a received radio communication signal; at a second mixer, mixing the input signal with a phase shifted oscillator signal to generate a Q component of the received radio communication signal; computing an estimate of second order distortion as a function of the I and Q components of the received radio communication signal; and adjusting an operational parameter of the radio receiver to reduce the estimated value of second order distortion components. This abstract is not to be considered limiting, since other embodiments may deviate from the features described in this abstract. | 09-18-2014 |
20140273905 | REDUCTION OF SECOND ORDER DISTORTION IN REAL TIME - In a radio receiver, a method of reducing second order distortion components, involves at a first mixer, mixing an input signal with an oscillator signal to generate an I component of a received radio signal; at a second mixer, mixing the input signal with a phase shifted oscillator signal to generate a Q component of the received radio signal; where the I and Q components of the received signal have a receive bandwidth; computing an estimate of second order distortion components as a power output of the I and Q components between approximately the receive bandwidth and twice the receive bandwidth of the received radio signals; and adjusting an operational parameter of the radio receiver to reduce the estimated value of second order distortion components. This abstract is not to be considered limiting. | 09-18-2014 |
20140274098 | STATISTICAL WEIGHTING AND ADJUSTMENT OF STATE VARIABLES IN A RADIO - A method involving receiving a real time communication signal at a radio receiver involves measuring at least one performance value associated with the radio receiver with an installed set of state variables; at a processor forming a part of the radio receiver: iteratively changing at least one of the state variables within a prescribed range in order to identify an improved value of the state variable that provides an improvement to the at least one performance value; storing the improved value of the state variable; applying a statistical weighting to the improved value and storing the statistical weighting; and adjusting the prescribed range of the state variable based upon the statistical weighting to provide a revised prescribed range that is statistically likely to contain state variable that provides improvement in the at least one performance value. This abstract is not to be considered limiting. | 09-18-2014 |
20150048966 | METHOD AND SYSTEM FOR IDENTIFYING AND FINDING A RANGE OF AN OBJECT - A method for identifying and ranging a wireless device, comprising: transmitting an original radar signal from a detecting system; in response to the original radar signal, receiving a modulated radar signal at the detecting system, the modulated radar signal being backscattered from an antenna of the wireless device and containing information pertaining to the wireless device, and the modulated radar signal being a frequency offset version of the original radar signal; and, using a processor at the detecting system, determining an identity and a range of the wireless device from the modulated radar signal. | 02-19-2015 |
20150070218 | METHOD AND SYSTEM FOR LOCATING WIRELESS DEVICES WITHIN A LOCAL REGION - A method for locating wireless devices within a local region, comprising: determining respective global locations of two or more of the wireless devices; determining whether the wireless devices are within the local region by calculating respective distances between the global locations; determining respective ranges between the wireless devices within the local region; and, determining respective relative locations of the wireless devices within the local region by triangulation using the ranges. | 03-12-2015 |